Black Diamond Therapeutics, Inc. beat EPS estimates 100% of the time across 3 reported quarters (3 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.18 | $-0.17 | +5.6% | Beat |
| Q12026 FY2026 | $-0.18 | $-0.16 | +11.1% | Beat |
| Q42025 FY2025 | $-0.18 | $-0.14 | +22.2% | Beat |
Back to BDTX overview · BDTX holders · BDTX KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.